Cue Biopharma
CUE • NASDAQ
Cue Biopharma is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Lucinda Warren, with a market cap of $23.4M.
Market Cap$23.4M
Employees53.0
CEOLucinda Warren
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 11, 2026 · in a monthQ1 2026
Financials
Cue Biopharma FAQ
Common questions about Cue Biopharma
Cue Biopharma is scheduled to report earnings for Q1 2026 on May 11, 2026. Analysts estimate revenue of $1.0M.
Cue Biopharma has approximately 53 employees.